Lifevantage (NASDAQ:LFVN) Shares Cross Above Two Hundred Day Moving Average – Here’s Why

Lifevantage Corporation (NASDAQ:LFVNGet Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.72 and traded as high as $6.34. Lifevantage shares last traded at $6.20, with a volume of 89,958 shares trading hands.

Analysts Set New Price Targets

A number of research firms have issued reports on LFVN. Lake Street Capital downgraded Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 price target for the company. in a research note on Thursday, May 7th. Weiss Ratings raised Lifevantage from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, May 26th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $5.00.

Read Our Latest Stock Report on LFVN

Lifevantage Stock Performance

The stock has a market cap of $78.24 million, a P/E ratio of 13.78 and a beta of 0.73. The company’s 50 day moving average price is $6.78 and its 200-day moving average price is $5.72.

Lifevantage (NASDAQ:LFVNGet Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.04). Lifevantage had a net margin of 2.94% and a return on equity of 23.89%. The firm had revenue of $43.72 million for the quarter, compared to the consensus estimate of $47.77 million. On average, analysts forecast that Lifevantage Corporation will post 0.6 earnings per share for the current fiscal year.

Lifevantage Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were given a dividend of $0.05 per share. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.20 annualized dividend and a dividend yield of 3.2%. This is an increase from Lifevantage’s previous quarterly dividend of $0.04. Lifevantage’s payout ratio is 44.44%.

Hedge Funds Weigh In On Lifevantage

Institutional investors have recently modified their holdings of the business. Cubist Systematic Strategies LLC bought a new stake in Lifevantage during the first quarter worth $97,000. Jones Financial Companies Lllp grew its stake in Lifevantage by 14,484.0% in the 1st quarter. Jones Financial Companies Lllp now owns 29,168 shares of the company’s stock valued at $425,000 after purchasing an additional 28,968 shares during the period. Goldman Sachs Group Inc. increased its position in shares of Lifevantage by 24.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 44,518 shares of the company’s stock valued at $649,000 after purchasing an additional 8,762 shares during the last quarter. Jane Street Group LLC increased its position in shares of Lifevantage by 5.4% during the 1st quarter. Jane Street Group LLC now owns 36,567 shares of the company’s stock valued at $533,000 after purchasing an additional 1,877 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of Lifevantage by 106.1% during the 2nd quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock worth $3,210,000 after purchasing an additional 126,274 shares during the period. 35.32% of the stock is owned by institutional investors.

About Lifevantage

(Get Free Report)

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.

Further Reading

Receive News & Ratings for Lifevantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifevantage and related companies with MarketBeat.com's FREE daily email newsletter.